BioMarin Pharmaceutical Inc. buy Raymond James
Start price
03.09.25
/
50%
€51.00
Target price
03.09.26
€73.07
Performance (%)
-7.33%
Price
27.01.26
€47.26
Summary
This prediction is currently active. With a performance of -7.33%, the BUY prediction by Raymond_James is trending in the wrong direction. This prediction currently runs until 03.09.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.665% | -1.665% |
| iShares Core DAX® | 1.130% | 2.184% |
| iShares Nasdaq 100 | 1.128% | -0.611% |
| iShares Nikkei 225® | 2.610% | 4.958% |
| iShares S&P 500 | -0.006% | -0.952% |
Comments by Raymond_James for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Raymond James Financial, Inc.. They set an "outperform" rating and a $85.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Raymond_James for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€63.66
10.10.24
10.10.24
€72.21
10.10.25
10.10.25
-28.37%
11.10.25
11.10.25
